<DOC>
	<DOCNO>NCT01859598</DOCNO>
	<brief_summary>The scientific use basal insulin great help individual government . However , study investigate real world use , effect , safety influence factor basal insulin China . This study evaluate use first basal insulin China patient type 2 diabetes inadequate glycemic control oral antidiabetic agent ( OADs ) naturalistic clinical practice .</brief_summary>
	<brief_title>Observational Registry Basal Insulin Treatment Study ( ORBIT )</brief_title>
	<detailed_description>This 6-month multicentre , observational , prospective , registry study . About 200 hospital different part China take part study , 20,000 patient type 2 diabetes mellitus ( T2DM ) inadequately control OADs willing accept basal insulin ( BI ) treatment consecutively enrol 12 month period . The study participant include baseline ( 0 month ) , 3 month end point ( 6 month ) collect study information . The project probably last 18 month .</detailed_description>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>1880 year old Type 2 diabetic patient Taking OADs inclusion Recently test HbA1c &gt; =7 % site within 3 month Being suggest physician start basal insulin ( BI ) treatment Willing start prescribe BI treatment Willing join registry study sign inform consent Diagnosed type 1 diabetes Received type insulin last 2 year ( except intermittent use insulin le 1 month time ) With severe health problem , situation judge investigator , difficult 6 month followup Current plan pregnant , lactating woman Involved clinical trial simultaneously 1 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>diabetes</keyword>
	<keyword>basal insulin</keyword>
	<keyword>effectiveness safety</keyword>
	<keyword>oral antidiabetic drug</keyword>
	<keyword>real world clinical practice</keyword>
</DOC>